Published Research
Published Research
CRISPR-engineered T cells in Patients with Refractory Cancer
February 28, 2020The University of Pennsylvania
ILC2s amplify PD-1 Blockade by Activating Tissue-specific Cancer Immunity
February 19, 2020B cells and tertiary lymphoid structures promote immunotherapy response
January 15, 2020The University of Texas MD Anderson Cancer Center
MHC-II neoantigens shape tumour immunity and response to immunotherapy
October 23, 2019Washington University School of Medicine
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
October 17, 2019Dana-Farber Cancer Institute
Multiplex single-cell tracing across time and division states enables control of T-cell differentiation
February 11, 2019Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
February 11, 2019University of California, Los Angeles
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
January 29, 2019Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
November 14, 2018University of California, San Francisco